Abstract
β (1)-adrenergic receptor (β (1)-AR), a member in the family of G-protein-coupled receptors, is a transmembrane receptor of great significance in the heart. Physiologically, catecholamines activate β (1)-AR to initiate a positive chronotropic, inotropic, and dromotropic change. It is believed that β (1)-AR couples to Gs protein and transmits the signal through second messenger cAMP. However, increasing research shows that β (1)-AR can also bind with Gi protein in addition to Gs. When β (1)-AR-Gi is biasedly activated, cardioprotective effects are introduced by the activated cGMP-protein kinase G (PKG) pathway and the transactivation of epidermal growth factor receptor (EGFR) pathway. The discovery of β (1)-AR-Gi signaling makes us reconsider the selectivity of G protein with regard to β (1)-AR, which also provides new ideas for the treatment of heart diseases. This review summarizes the discovery of β (1)-AR-Gi pathway, including the evidence that supports β (1)-AR's capability to couple Gi, details of the transduction process and functions of the β (1)-AR-Gi signaling pathway.